spacer
home > pmps > summer 2017 > secure systems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Secure Systems

Quality and safety in drug manufacturing are overriding concerns. Regulators are now tightening their grip on the integrity of all produced data. In the pharmaceutical industry, standards require close monitoring of drug development and logistics to guarantee their quality, safety and efficacy, which results in numerous differing measurements that produce an ever-growing amount of data. This information has to be kept safe, available and traceable. However, until now, the guidance provided by regulators has not focused on data integrity, thus inherent problems with data collection and storage are not being addressed.

Targeting Data Integrity

Regulators have found gaps between industry practice and existing technology. Many companies have misinterpreted earlier guidance or do not know how to apply its demands to their systems. As a result, they do not achieve sufficient data integrity.

Publication of Good Manufacturing Practice (GMP) non-compliance reports, warning letters, import alerts and notices have clarified that regulators are targeting honest information failures in their current inspections. Subsequent enforcement actions have led to supply withdrawals, product recalls and consent decrees across multiple markets. They have also damaged the reputation of the companies involved to a varying degree. With regulators increasingly targeting integrity, understanding correct data management practices is crucial.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Piritta Maunu is an Industrial Measurement Expert at Vaisala, with many years of experience in biotechnology. She has worked in quality management, R&D and GMP production. Piritta holds an MSc in cell biology and is an instructor of general biology. As a manufacturer of environmental measurement and monitoring systems, Vaisala is invested in understanding the relationship between computerised systems, network functionality, device capabilities and data integrity. Over the past decade, Vaisala has continuously developed its viewLinc monitoring system software, which strives to ensure data integrity. 
spacer
Piritta Maunu
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wickham Laboratories to present at Cleanroom Technology Conference 2018

We are pleased to announce our CEO, Dr John McKenzie, will be presenting on ‘Microbiological Considerations in Cleanroom Validation’ at the Cleanroom Technology Conference to be held 16th-17th May, 2018.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 
Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement